Search research articles
Contact Us
Filters
Showing results (491-500 of 558) with videos related to
Page
of 56
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2002
Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas
David A Reardon, Gamal Akabani, R Edward Coleman, et al.
Annals of Neurology
|
January 3, 2013
Laminin alpha 2 enables glioblastoma stem cell growth
Justin D Lathia, Meizhang Li, Peter E Hall, et al.
Cell Stem Cell
|
April 16, 2019
Single-Cell Transcriptomics Uncovers Glial Progenitor Diversity and Cell Fate Determinants during Development and Gliomagenesis
Qinjie Weng, Jincheng Wang, Jiajia Wang, et al.
Cancer Cell
|
October 14, 2015
Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells
David L Schonberg, Tyler E Miller, Qiulian Wu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 13, 2023
Transgelin Promotes Glioblastoma Stem Cell Hypoxic Responses and Maintenance Through p53 Acetylation
Huan Li, Chao Song, Yang Zhang, et al.
Nature Communications
|
September 13, 2022
SREBP2-dependent lipid gene transcription enhances the infection of human dendritic cells by Zika virus
Emilie Branche, Ying-Ting Wang, Karla M Viramontes, et al.
Science Translational Medicine
|
June 1, 2018
Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance
Yu Shi, Olga A Guryanova, Wenchao Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2002
Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma
Jennifer A Quinn, James Pluda, M Eileen Dolan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2005
Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results
David A Reardon, Gamal Akabani, R Edward Coleman, et al.
Cell Stem Cell
|
December 20, 2016
Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance
Brian B Liau, Cem Sievers, Laura K Donohue, et al.
Page
of 56
Search research articles
Search
Showing results (491-500 of 558) with videos related to
Sort By:
Page
of 56
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2002
Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas
David A Reardon, Gamal Akabani, R Edward Coleman, et al.
Annals of Neurology
|
January 3, 2013
Laminin alpha 2 enables glioblastoma stem cell growth
Justin D Lathia, Meizhang Li, Peter E Hall, et al.
Cell Stem Cell
|
April 16, 2019
Single-Cell Transcriptomics Uncovers Glial Progenitor Diversity and Cell Fate Determinants during Development and Gliomagenesis
Qinjie Weng, Jincheng Wang, Jiajia Wang, et al.
Cancer Cell
|
October 14, 2015
Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells
David L Schonberg, Tyler E Miller, Qiulian Wu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 13, 2023
Transgelin Promotes Glioblastoma Stem Cell Hypoxic Responses and Maintenance Through p53 Acetylation
Huan Li, Chao Song, Yang Zhang, et al.
Nature Communications
|
September 13, 2022
SREBP2-dependent lipid gene transcription enhances the infection of human dendritic cells by Zika virus
Emilie Branche, Ying-Ting Wang, Karla M Viramontes, et al.
Science Translational Medicine
|
June 1, 2018
Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance
Yu Shi, Olga A Guryanova, Wenchao Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2002
Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma
Jennifer A Quinn, James Pluda, M Eileen Dolan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2005
Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results
David A Reardon, Gamal Akabani, R Edward Coleman, et al.
Cell Stem Cell
|
December 20, 2016
Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance
Brian B Liau, Cem Sievers, Laura K Donohue, et al.
Page
of 56